Advisors Asset Management, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1297376
Monument, CO
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,947,427
+$443,577 QoQ
Shares Held
17,488
-8.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#264
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $29,351,232 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
885,796 | $14,066,440 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,119 | $6,566,437 | |
| 3 | ZTS |
Zoetis Inc.
|
51,264 | $3,683,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
17,488 | $2,947,427 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,884 | $843,069 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,309 | $389,673 | |
| 7 | ALKS |
Alkermes plc.
|
7,425 | $389,070 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
23,253 | $336,935 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,947,427 | 17,488 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,503,850 | 19,006 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,288,612 | 23,187 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $4,371,854 | 31,143 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,982,990 | 31,689 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,065,766 | 36,761 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,967,917 | 36,395 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $4,444,726 | 38,576 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $4,684,497 | 34,027 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $4,501,846 | 32,641 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,021,652 | 22,933 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,444,400 | 21,728 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,628,706 | 27,876 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,822,823 | 27,888 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,267,639 | 27,358 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,290,737 | 21,568 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,969,778 | 20,207 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,447,031 | 15,435 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,605,284 | 18,848 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,924,913 | 20,070 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,161,477 | 22,210 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,062,867 | 21,212 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,969,142 | 20,544 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,705,301 | 17,734 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,235,528 | 18,324 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,295,913 | 14,973 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||